COGT - Cogent Biosciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

COGT is currently covered by 9 analysts with an average price target of $21.21. This is a potential upside of $9.16 (76.02%) from yesterday's end of day stock price of $12.05.

Cogent Biosciences's activity chart (see below) currently has 34 price targets and 79 ratings on display. The stock rating distribution of COGT is 73.08% BUY and 26.92% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.19% with an average time for these price targets to be met of 71.3 days.

Highest price target for COGT is $29, Lowest price target is $9, average price target is $18.33.

Most recent stock forecast was given by DAVID LEBOWITZ from CITI on 18-Jul-2025. First documented stock forecast 23-Apr-2018.

Currently out of the existing stock ratings of COGT, 38 are a BUY (73.08%), 14 are a HOLD (26.92%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$22

$10.58 (92.64%)

$15

17 days ago
(18-Jul-2025)

1/4 (25%)

$9.51 (76.14%)

209

Buy

$29

$17.58 (153.94%)

$25

25 days ago
(10-Jul-2025)

0/6 (0%)

$18.15 (167.28%)

Buy

$22

$10.58 (92.64%)

$12

27 days ago
(08-Jul-2025)

1/12 (8.33%)

$12.22 (124.95%)

58

Hold

$9

$-2.42 (-21.19%)

$7

27 days ago
(08-Jul-2025)

4/7 (57.14%)

$-0.78 (-7.98%)

78

Buy

$18

$6.58 (57.62%)

$16

28 days ago
(07-Jul-2025)

1/5 (20%)

$8.65 (92.51%)

65

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is COGT (Cogent Biosciences) average time for price targets to be met?

On average it took 71.3 days on average for the stock forecasts to be realized with a an average price target met ratio 23.19

Which analyst has the current highest performing score on COGT (Cogent Biosciences) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the most public recommendations on COGT (Cogent Biosciences)?

David Nierengarten works at WEDBUSH and has 8 price targets and 5 ratings on COGT

Which analyst is the currently most bullish on COGT (Cogent Biosciences)?

Anupam Rama with highest potential upside - $17.58

Which analyst is the currently most reserved on COGT (Cogent Biosciences)?

Joel Beatty with lowest potential downside - -$2.42

Cogent Biosciences in the News

Noteworthy Monday Option Activity: PRME, ELF, COGT

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Prime Medicine Inc (Symbol: PRME), where a total of 23,856 contracts have traded so far, representing approximately 2.4 million underlying shares. That amounts to about 64.6% of PRME’s average daily trading volume over the past month of 3.7...

Cogent surges as bezuclastinib meets key goal in phase 2 mastocytosis trial

[Financial bar graph on futuristic digital landscape with glowing data] AlexSecret Cogent Biosciences (NASDAQ:COGT [https://seekingalpha.com/symbol/COGT]) surged ~31% Monday after releasing positive mid-stage data on bezuclastinib, its candidate for non-advanced systemic mastocytosis. Bezuclastinib met its primary endpoint, a highly statistically significant difference in the mean change in total symptom score (TSS) at 24 weeks versus placebo....
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?